Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
39.59
+0.38 (0.97%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Sionna Therapeutics Employees
Sionna Therapeutics had 59 employees as of December 31, 2025. The number of employees increased by 18 or 43.90% compared to the previous year.
Employees
59
Change (1Y)
18
Growth (1Y)
43.90%
Revenue / Employee
n/a
Profits / Employee
-$1,275,729
Market Cap
1.79B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 59 | 18 | 43.90% |
| Dec 31, 2024 | 41 | 13 | 46.43% |
| Dec 31, 2023 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Galapagos NV | 558 |
| Vericel | 398 |
| Nurix Therapeutics | 317 |
| Syndax Pharmaceuticals | 298 |
| Harmony Biosciences Holdings | 293 |
| Innoviva | 159 |
| Pharvaris | 129 |
SION News
- 1 day ago - Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis - GlobeNewsWire
- 21 days ago - Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium - GlobeNewsWire
- 7 weeks ago - Sionna Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Sionna Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences - GlobeNewsWire
- 2 months ago - Sionna Therapeutics Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts
- 2 months ago - Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire